Compare
Lilly (Eli) vs Zoetis (LLY vs ZTS)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Lilly (Eli) (LLY) returned +46.2% and Zoetis (ZTS) -34.1%; so far this year the figures are +26.0% and -36.9%.
Lilly (Eli) is the larger company by market value, about 39.5 times the size of Zoetis.
On trailing earnings, LLY trades at 43.9 times and ZTS at 13.4 times.
Revenue grew +45.5% at LLY and +0.9% at ZTS over the last year.
LLY yields 0.49%. ZTS yields 2.67%.
Data as of the latest close. Not investment advice.
Relative performance
| LLY | ZTS | |
|---|---|---|
| Price | $1,354.00 | $79.40 |
| 1-day | -0.79% | -3.30% |
| YTD | +25.99% | -36.89% |
| 1 year | +46.25% | -34.10% |
| 3 years | +144.20% | -47.57% |
| Market cap | $1.27T | $32.3B |
| P/E | 43.9 | 13.4 |
| P/S | 14.73 | 3.40 |
| P/B | 31.63 | 9.77 |
| Revenue growth | +45.50% | +0.90% |
| EPS growth | +50.70% | +0.70% |
| Gross margin % | 83.6 | 71.6 |
| Net margin % | 31.9 | 26.4 |
| ROE % | 68.5 | 75.9 |
| Debt / equity | 1.23 | 2.74 |
| FCF yield % | 2.4 | 6.9 |
| Dividend yield % | 0.49 | 2.67 |
| Beta | 0.29 | 0.59 |
| RSI (14) | 61.1 | 51.1 |
| Technical rating |